Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia

@article{Baranovskii2020ProlongedPT,
  title={Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia},
  author={Denis S. Baranovskii and Ilya D. Klabukov and Olga Aleksandrovna Krasilnikova and Dimitri A. Nikogosov and Natalia V. Polekhina and Delyara R. Baranovskaia and Leonid Aleksandrovich Laberko},
  journal={Current Medical Research and Opinion},
  year={2020},
  pages={1 - 8}
}
Abstract Background Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. The evaluation of laboratory findings including coagulation and inflammation parameters may represent a promising approach for early determination of COVID-19 severity. Methods and Materials In the present study, we aimed to identify laboratory parameters present upon… 
View on Taylor & Francis
hal.archives-ouvertes.fr
10 Citations
Highly Influential Citations
1
Background Citations
3
Methods Citations
2
Results Citations
2

10 Citations

Major coagulation disorders and parameters in COVID-19 patients

The most commonly reported problems of COVID-19 patients, such as venous thromboembolism, pulmonary emblism, disseminated intravascular coagulation, etc, are reviewed and the causes are investigated and the treatment options are briefly reviewed.

Involvement of the Liver in COVID-19: A Systematic Review

The important liver manifestations of COVID-19 are outlined, the possible underlying pathophysiological mechanisms and their diagnosis and management are discussed, and special emphasis is needed in those with nonalcoholic fatty liver disease, cirrhosis, hepatocellular carcinoma, hepatitis B and C infections, and alcoholic liver disease and in liver transplant recipients.

Novel models for early prediction and prevention of acute respiratory distress syndrome in patients following hepatectomy: A clinical translational study based on 1,032 patients

Two simple and practical prediction models for early predicting postoperative Acute respiratory distress syndrome in patients undergoing hepatectomy are developed to improve clinicians’ ability to early estimate the risk of postoperative ARDS and timely prevent its emergence.

Comparison of Clinical Characteristics and Predictors of Mortality between Direct and Indirect ARDS

The patients with direct ARDS were more likely to be older and male and have worse conditions and prognoses than those with indirect ARDS, suggesting the need for different management strategies of ARDS.

Prognostic Model of ICU Admission Risk in Patients with COVID-19 Infection Using Machine Learning

A stacking machine learning model was proposed and compared with eight different classification algorithms to detect risk of need for ICU admission for both COVID-19 and non-COVID patients combined and COVID patients alone, and the best performance was produced by the stacking approach.

Individual Characteristics as Prognostic Factors of the Evolution of Hospitalized COVID-19 Romanian Patients: A Comparative Observational Study between the First and Second Waves Based on Gaussian Graphical Models and Structural Equation Modeling

The main results highlight that the specific treatment methods applied had a positive influence on the evolution of COVID-19 patients, particularly in the second wave of coronavirus pandemic.

A complete framework for accurate recognition and prognosis of COVID-19 patients based on deep transfer learning and feature classification approach

The sudden appearance of COVID-19 has put the world in a serious situation. Due to the rapid spread of the virus and the increase in the number of infected patients and deaths, COVID-19 was declared…

Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy

Findings reveal that HEJG modulates the pharmacokinetics of CYP substrate-drug(s) by inactivating CYP3A, providing key information for both clinicians and patients to use herb–drug combinations for antiviral therapy in a scientific and reasonable way.

Original Abstracts from the 2022 European Meeting of ISMPP

The use of Twitter by pharmaceutical companies to publicise journal publications and engagement differences between plain language summary (PLS) formats of the journal Future Oncology showed that standalone PLSs provide a greater reach of information compared with other formats.

A BRBES to Support Diagnosis of COVID-19 Using Clinical and CT Scan Data

References

SHOWING 1-10 OF 16 REFERENCES

Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort

Fibrinogen seems to increase early in COVID-19 patients and may be used as a risk stratification marker for the early detection of a subgroup of CO VID-19 patient at increased risk to develop SARS, who might benefit from a different and thorough clinical surveillance and treatment.

Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID‐19

A meta-analysis of 31 studies involving 7613 participants and found a significant association between thrombocytopenia and severe COVID-19 hospitalized patients or poor outcome in this setting, however, other clinical, biological and radiological factors strongly impact CO VID-19 outcome.

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

A period of 7–13 days after illness onset is the critical stage in the COVID-19 course, which shows persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death.

COVID‐19 and the clinical hematology laboratory

The laboratory's role in the diagnosis of COVID‐19 infection is discussed, the current state of biomarker analysis in COVID'S infection is summarized, and the impact of the pandemic has had on organized national and international educational activities worldwide is described.

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk, including patients with cardiovascular comorbidity.

Coagulation and inflammation biomarkers may help predict the severity of community‐acquired pneumonia

The aim of this study was to evaluate the association between the severity of CAP and serum levels of antithrombin III (AT‐III), protein C (P‐C), D‐dimers (D‐D) and CRP, at hospital admission.

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

COVID-19 cases in the United States that occurred during February 12-March 16, 2020 and severity of disease (hospitalization, admission to intensive care unit [ICU], and death) were analyzed by age group, suggesting that the risk for serious disease and death from CO VID-19 is higher in older age groups.

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

This work aims to contribute towards the humanizing of thrombosis and Haemostasis by promoting awareness of the importance of proper diagnosis and treatment of these conditions in patients.